The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PLSE FINANCIAL STATEMENTS

Pulse Biosciences Inc — balance sheet, income statement and cash flow trends

PLSEPulse Biosciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Instruments & Supplies

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-75 M-50 M-25 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue1.2 M $Gross Profit-256 K $ · -22%Operating Income-83 M $ · -7008%Pre-tax Income-80.1 M $ · -6756%Net Income to Owners-80.1 M $ · -6756%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue1.2 M $-52.5%
Gross Profit-256 K $-1,806.7%
Operating Income-83 M $—
EBITDA-79.9 M $—
Net Income to Owners-80.1 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 M100 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets115.6 M
  • Equity99.5 M $86%
  • Current Liabilities11 M $9%
  • Long-term Liabilities5.1 M $4%

Key Figures

YoY change
Total Assets115.6 M $-3.9%
Total Liabilities16.1 M $+1.9%
Total Equity99.5 M $-4.8%
Cash & ST Investments101.6 M $-4.4%
Total Debt6.8 M $-17.9%
Net Debt-94.8 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-60 M-40 M-20 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-60 M-40 M-20 M0-61.1 M $Operating-290 K $Investing56.7 M $Financing-4.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-61.1 M $—
Capital Expenditures290 K $+21.3%
Free Cash Flow-61.4 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PLSE

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.